| P50 | author | Susana Patrícia Lopes | Q59659733 |
| | Nuno F. Azevedo | Q42273667 |
| | Maria Olívia Pereira | Q44609863 |
| P2093 | author name string | Maria O Pereira | |
| | Nuno F Azevedo | |
| | Susana P Lopes | |
| P2860 | cites work | Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients | Q21562196 |
| | Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients | Q24551181 |
| | A decade of Burkholderia cenocepacia virulence determinant research | Q24594813 |
| | A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients | Q24652357 |
| | Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia | Q24672751 |
| | Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa | Q24676453 |
| | Microbiology of airway disease in a cohort of patients with cystic fibrosis | Q25256069 |
| | Two quorum sensing systems control biofilm formation and virulence in members of the Burkholderia cepacia complex | Q26827817 |
| | Cystic fibrosis therapy: a community ecology perspective | Q27015964 |
| | Pseudomonas aeruginosa biofilms in cystic fibrosis | Q28299966 |
| | The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management | Q28730299 |
| | Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients | Q46131950 |
| | Method for detection of respiratory viruses in the sputa of patients with cystic fibrosis. | Q47875112 |
| | Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. | Q50495768 |
| | Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. | Q50561588 |
| | Microbial ecology and adaptation in cystic fibrosis airways. | Q51173006 |
| | Nocardia asteroides isolated from three patients with cystic fibrosis. | Q51720403 |
| | High prevalence of Pneumocystis jirovecii colonization in Brazilian cystic fibrosis patients. | Q54331982 |
| | Bacteriophages and diffusion of genes encoding antimicrobial resistance in cystic fibrosis sputum microbiota | Q56220182 |
| | Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis | Q57913654 |
| | Sputum Candida albicans Presages FEV 1 Decline and Hospital-Treated Exacerbations in Cystic Fibrosis | Q58817659 |
| | Evolution of species interactions in a biofilm community | Q59055799 |
| | Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis | Q59139101 |
| | Bacterial-fungal interactions: hyphens between agricultural, clinical, environmental, and food microbiologists | Q28741795 |
| | CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE | Q29036696 |
| | Lung infections associated with cystic fibrosis | Q30080000 |
| | Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov | Q30695296 |
| | Burkholderia cenocepacia sp. nov.--a new twist to an old story. | Q30778756 |
| | Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. | Q31030261 |
| | Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. | Q33185288 |
| | Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis | Q33310144 |
| | Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients | Q33358120 |
| | Airway infection with a novel Cupriavidus species in persons with cystic fibrosis | Q33482631 |
| | Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals | Q33509530 |
| | Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients | Q33550582 |
| | Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection | Q33622945 |
| | Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. | Q33633034 |
| | Outbreak of Corynebacterium pseudodiphtheriticum infection in cystic fibrosis patients, France | Q33647480 |
| | Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients | Q33705998 |
| | Airway colonization by Acrophialophora fusispora in patients with cystic fibrosis | Q33752887 |
| | The changing microbial epidemiology in cystic fibrosis | Q33825634 |
| | Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention | Q33828309 |
| | Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis | Q33862073 |
| | Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis | Q33885159 |
| | Geosmithia argillacea: an emerging pathogen in patients with cystic fibrosis. | Q33963545 |
| | Isolation of the fungus Geosmithia argillacea in sputum of people with cystic fibrosis | Q33963639 |
| | Virulence of an emerging respiratory pathogen, genus Pandoraea, in vivo and its interactions with lung epithelial cells | Q34153096 |
| | Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth | Q34167016 |
| | Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis | Q34196570 |
| | Decade-long bacterial community dynamics in cystic fibrosis airways | Q34209009 |
| | Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy. | Q34281524 |
| | Isolation of fungi, especially Exophiala dermatitidis, in patients suffering from cystic fibrosis. A prospective study | Q34341838 |
| | Changes in cystic fibrosis airway microbiota at pulmonary exacerbation | Q34353683 |
| | Clinical significance of microbial infection and adaptation in cystic fibrosis | Q34491552 |
| | Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy | Q34554419 |
| | Pulmonary infections in patients with cystic fibrosis | Q34561212 |
| | Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis | Q34796605 |
| | Wide host range and strong lytic activity of Staphylococcus aureus lytic phage Stau2. | Q42120556 |
| | Treatment of pseudomonas aeruginosa colonisation in cystic fibrosis | Q42245391 |
| | Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation | Q42851594 |
| | Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media. | Q42929571 |
| | Haemophilus influenzae forms biofilms on airway epithelia: implications in cystic fibrosis | Q43153735 |
| | Pseudomonas aeruginosa secreted factors impair biofilm development in Candida albicans | Q43164831 |
| | Bacteriophage-derived enzyme that depolymerizes the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa | Q43285538 |
| | Sputum isolation of Wangiella dermatitidis in patients with cystic fibrosis. | Q43811919 |
| | Viral and atypical bacterial infections in the outpatient pediatric cystic fibrosis clinic | Q44237751 |
| | Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis | Q44436327 |
| | Exophiala dermatitidis pneumonia in cystic fibrosis | Q44514457 |
| | Microbiology of sputum from patients at cystic fibrosis centers in the United States | Q44982403 |
| | Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum | Q45044337 |
| | Rhinovirus C and respiratory exacerbations in children with cystic fibrosis | Q34907979 |
| | Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosis | Q34995831 |
| | Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis | Q35213050 |
| | Non-tuberculous mycobacteria in cystic fibrosis | Q35532270 |
| | Infection control in cystic fibrosis | Q35545544 |
| | Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. | Q35638889 |
| | Polymicrobial interactions: impact on pathogenesis and human disease | Q35666253 |
| | Bacterial cis-2-unsaturated fatty acids found in the cystic fibrosis airway modulate virulence and persistence of Pseudomonas aeruginosa | Q35896321 |
| | Case studies of the spatial heterogeneity of DNA viruses in the cystic fibrosis lung | Q35991304 |
| | Infection and inflammation in cystic fibrosis: a short review | Q36170129 |
| | Relationship of airway epithelial ion transport to chronic bronchitis | Q36236773 |
| | Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients | Q36394784 |
| | In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections | Q36540547 |
| | The cystic fibrosis airway microbiome | Q36629083 |
| | Cystic fibrosis: a polymicrobial infectious disease | Q36895733 |
| | Development of an oligonucleotide array for direct detection of fungi in sputum samples from patients with cystic fibrosis | Q37051407 |
| | Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage | Q37069059 |
| | Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis | Q37125716 |
| | Antibiotic and anti-inflammatory therapies for cystic fibrosis | Q37201467 |
| | Preventing biofilms of clinically relevant organisms using bacteriophage | Q37375379 |
| | characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling | Q37597340 |
| | Antibiotic resistance of bacterial biofilms | Q37690946 |
| | Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity | Q37705435 |
| | Bacteriophages as vehicles of the resistome in cystic fibrosis. | Q37911731 |
| | Eradication therapy for Pseudomonas aeruginosa colonization episodes in cystic fibrosis patients not chronically colonized by P. aeruginosa | Q38039669 |
| | Treatment of lung infection in patients with cystic fibrosis: current and future strategies | Q38058617 |
| | Pneumocystis jirovecii and cystic fibrosis in France | Q38418192 |
| | Interactions between Viruses and Bacteria in Patients with Chronic Bronchitis | Q39127436 |
| | Antibiotic resistance of mixed biofilms in cystic fibrosis: impact of emerging microorganisms on treatment of infection. | Q39590412 |
| | Emergence of Scedosporium apiospermum in patients with cystic fibrosis | Q40304988 |
| | Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. | Q40624126 |
| | Antifungal susceptibilities of the species of the Pseudallescheria boydii complex | Q40903665 |
| | Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. | Q40968095 |
| | First isolation of two colistin-resistant emerging pathogens, Brevundimonas diminuta and Ochrobactrum anthropi, in a woman with cystic fibrosis: a case report | Q41896105 |
| | Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum | Q42054384 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cystic fibrosis | Q178194 |
| | microbiome | Q1330402 |
| P304 | page(s) | 353-365 | |
| P577 | publication date | 2014-03-19 | |
| P1433 | published in | Critical Reviews in Microbiology | Q5186671 |
| P1476 | title | Microbiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy | |
| P478 | volume | 41 | |